158 related articles for article (PubMed ID: 30875134)
1. The peripheral differentiation of human natural killer T cells.
Liu J; Hill BJ; Darko S; Song K; Quigley MF; Asher TE; Morita Y; Greenaway HY; Venturi V; Douek DC; Davenport MP; Price DA; Roederer M
Immunol Cell Biol; 2019 Jul; 97(6):586-596. PubMed ID: 30875134
[TBL] [Abstract][Full Text] [Related]
2. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
3. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
Gerth E; Mattner J
Front Immunol; 2019; 10():1449. PubMed ID: 31293596
[TBL] [Abstract][Full Text] [Related]
4. The sequential activity of Gata3 and Thpok is required for the differentiation of CD1d-restricted CD4+ NKT cells.
Wang L; Carr T; Xiong Y; Wildt KF; Zhu J; Feigenbaum L; Bendelac A; Bosselut R
Eur J Immunol; 2010 Sep; 40(9):2385-90. PubMed ID: 20706986
[TBL] [Abstract][Full Text] [Related]
5. CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection.
Fleuridor R; Wilson B; Hou R; Landay A; Kessler H; Al-Harthi L
Immunology; 2003 Jan; 108(1):3-9. PubMed ID: 12519296
[TBL] [Abstract][Full Text] [Related]
6. Isolation and Functional Use of Human NKT Cells.
Exley MA; Wilson SB; Balk SP
Curr Protoc Immunol; 2017 Nov; 119():14.11.1-14.11.20. PubMed ID: 29091262
[TBL] [Abstract][Full Text] [Related]
7. Impairment of CD1d-restricted natural killer T cells in chronic HIV type 1 clade C infection.
Mureithi MW; Cohen K; Moodley R; Poole D; Mncube Z; Kasmar A; Moody DB; Goulder PJ; Walker BD; Altfeld M; Ndung'u T
AIDS Res Hum Retroviruses; 2011 May; 27(5):501-9. PubMed ID: 20942750
[TBL] [Abstract][Full Text] [Related]
8. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.
Pellicci DG; Hammond KJ; Uldrich AP; Baxter AG; Smyth MJ; Godfrey DI
J Exp Med; 2002 Apr; 195(7):835-44. PubMed ID: 11927628
[TBL] [Abstract][Full Text] [Related]
9. CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells.
Thomas SY; Hou R; Boyson JE; Means TK; Hess C; Olson DP; Strominger JL; Brenner MB; Gumperz JE; Wilson SB; Luster AD
J Immunol; 2003 Sep; 171(5):2571-80. PubMed ID: 12928408
[TBL] [Abstract][Full Text] [Related]
10. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
Sköld M; Faizunnessa NN; Wang CR; Cardell S
J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
[TBL] [Abstract][Full Text] [Related]
11. Directing traffic on the NKT-cell highway: a key role for ThPOK.
Chakravarti S; Godfrey DI
Eur J Immunol; 2010 Sep; 40(9):2372-5. PubMed ID: 20809492
[TBL] [Abstract][Full Text] [Related]
12. CD8
Kumari S; Shivam P; Hansa J; Jamal F; Singh MK; Bimal S; Narayan S; Pandey K; Das VNR; Das P; Singh SK
Hum Immunol; 2018 Aug; 79(8):616-620. PubMed ID: 29842895
[TBL] [Abstract][Full Text] [Related]
13. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
[TBL] [Abstract][Full Text] [Related]
14. CD4(+)CD8(+)TCR(low) thymocytes express low levels of glucocorticoid receptors while being sensitive to glucocorticoid-induced apoptosis.
Wiegers GJ; Knoflach M; Böck G; Niederegger H; Dietrich H; Falus A; Boyd R; Wick G
Eur J Immunol; 2001 Aug; 31(8):2293-301. PubMed ID: 11477541
[TBL] [Abstract][Full Text] [Related]
15. Human natural killer T cells are heterogeneous in their capacity to reprogram their effector functions.
Eger KA; Sundrud MS; Motsinger AA; Tseng M; Van Kaer L; Unutmaz D
PLoS One; 2006 Dec; 1(1):e50. PubMed ID: 17183680
[TBL] [Abstract][Full Text] [Related]
16. Identification of CD4(-)CD8(-) double-negative natural killer T cell precursors in the thymus.
Dashtsoodol N; Watarai H; Sakata S; Taniguchi M
PLoS One; 2008; 3(11):e3688. PubMed ID: 18997862
[TBL] [Abstract][Full Text] [Related]
17. Ex-vivo analysis of human natural killer T cells demonstrates heterogeneity between tissues and within established CD4(+) and CD4(-) subsets.
Chan AC; Leeansyah E; Cochrane A; d'Udekem d'Acoz Y; Mittag D; Harrison LC; Godfrey DI; Berzins SP
Clin Exp Immunol; 2013 Apr; 172(1):129-37. PubMed ID: 23480193
[TBL] [Abstract][Full Text] [Related]
18. Alternative pathway for the development of V
Dashtsoodol N; Shigeura T; Aihara M; Ozawa R; Kojo S; Harada M; Endo TA; Watanabe T; Ohara O; Taniguchi M
Nat Immunol; 2017 Mar; 18(3):274-282. PubMed ID: 28135253
[TBL] [Abstract][Full Text] [Related]
19. CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes.
Kadri N; Korpos E; Gupta S; Briet C; Löfbom L; Yagita H; Lehuen A; Boitard C; Holmberg D; Sorokin L; Cardell SL
J Immunol; 2012 Apr; 188(7):3138-49. PubMed ID: 22371394
[TBL] [Abstract][Full Text] [Related]
20. A model system for T-lymphocyte differentiation: regulation of CD4 and CD8 gene expression in SL12.4 T-lymphoma cell clones.
Wilkinson MF; Fong AM; Huynh H; Hays EF; MacLeod CL
Mol Immunol; 1991; 28(1-2):57-68. PubMed ID: 1672730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
